Form 4: Director Bruce Hoechner Receives Ingevity Stock Grant
Statement of Changes in Beneficial Ownership
Ingevity Corporation director Bruce D. Hoechner was granted 1,904 deferred stock units in lieu of his annual restricted stock unit award.
Summary
- Director Bruce D. Hoechner acquired 1,904 deferred stock units (DSUs) on April 30, 2026.
- The grant was issued in lieu of the standard annual non-employee director restricted stock unit award.
- Following this transaction, the director's total beneficial ownership of Ingevity common stock is 10,732 shares.
- The DSUs are scheduled to vest on April 30, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no material impact on the company's financial outlook.
Positives
- The transaction reflects an alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified.
Risks
- The value of the deferred stock units is subject to the future market performance of Ingevity Corporation common stock.
Future Outlook
The deferred stock units will settle into common stock upon the director's termination of board service, subject to the company's incentive plans.
Industry Context
StockSavvy.ai notes that director equity grants in lieu of cash or standard RSU awards are a common corporate governance practice designed to ensure board members maintain a significant stake in the company's long-term performance.
Comparison to Industry Standards
- The use of deferred stock units for non-employee directors is consistent with standard compensation practices for S&P 400/Small-cap industrial companies.
- The vesting period of one year is standard for annual director equity awards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Election | Director elected to receive deferred stock units in lieu of annual restricted stock unit grant. | 04/30/2026 | Neutral; standard compensation adjustment. |
Stakeholder Impact
- Shareholders: Minimal impact; reflects standard director compensation structure.
Next Steps
- Vesting of the 1,904 deferred stock units on April 30, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/30/2026 | Date of the transaction involving the grant of deferred stock units. |
| 04/30/2027 | Vesting date for the granted deferred stock units. |
| 05/01/2026 | Date of the filing signature. |
Keywords
Ingevity, NGVT, Director Compensation, Insider Trading, Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.